Abstract: A method for communicating temperature information of a high voltage battery system of an electrified vehicle is provided. The method includes: receiving, at a controller, sensed parameters including a maximum temperature of the high voltage battery system and a coolant temperature at the high voltage battery system; determining, at the controller, cool down parameters indicative of a time required to return the high voltage battery system from an elevated temperature to a reduced temperature suitable to achieve peak performance; sending, from the controller, a signal to a human machine interface indicative of the cool down parameters; and displaying, at the HMI, the cool down parameters.

Abstract: A vehicle system that communicates temperature information of a high voltage battery system of an electrified vehicle includes at least one temperature sensor, a controller, and a human machine interface (HMI). The at least one temperature sensor is disposed on at least one battery module of the high voltage battery system. The at least one temperature sensor is configured to sense a temperature of the at least one battery module. The controller receives the sensed temperature and determines a temperature profile of the high voltage battery system. The HMI is configured to convey temperature information of the high voltage battery system, wherein the controller communicates a signal to the HMI indicative of the temperature profile.

Abstract: A method for communicating temperature information of a high voltage battery system of an electrified vehicle is provided.

Abstract: A vehicle system that communicates temperature information of a high voltage battery system of an electrified vehicle includes at least one temperature sensor, a controller, and a human machine interface (HMI). The at least one temperature sensor is disposed on at least one battery module of the high voltage battery system. The at least one temperature sensor is configured to sense a temperature of the at least one battery module. The controller receives the sensed temperature and determines a temperature profile of the high voltage battery system. The HMI is configured to convey temperature information of the high voltage battery system, wherein the controller communicates a signal to the HMI indicative of the temperature profile.

Abstract: The invention includes compositions and methods for storage of at least one blood component of blood in a blood product. In certain embodiments, the blood component is contacted with a composition comprising adenosine and sphingosine 1-phosphate (S1P) prior to storage.

Abstract: This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.

Abstract: This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.

Abstract: Embodiments provide protective helmets configured to protect the head from linear and rotational acceleration in an impact. In various embodiments, the helmets may include an outer layer, an inner layer, and at least one intermediate layer coupled to the outer and inner layers by alternate fixation sites, thereby providing a suspension between the outer and inner layers. In various embodiments, the intermediate layer may be made from a honeycomb material, such as an aluminum honeycomb. In use, in-plane deformation of the honeycomb may allow for translation of the outer layer in a substantially tangential direction relative to the inner layer, thereby mitigating rotational acceleration imparted by the tangential impact component.

Abstract: This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.

Abstract: This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.

Abstract: This invention generally relates to pyrazolo pyrimidine derivatives useful as inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. The invention further relates to pharmaceutical compositions and methods of preventing or treating disease with 1H-Pyrrolo[2.3-d]pyrimidine derivatives. More specifically, the invention relates to a 1H-Pyrrolo[2.

Abstract: This invention generally relates to pyrazolo pyrimidine derivatives useful as, inter alia, inhibitors of short chain dehydrogenase/reductase (SDR) family of NAD(P)(H) dependent oxido-reductases. More specifically, the invention relates to pyrazolo pyrimidine derivatives, including derivatives and analogs of SDR inhibitors, pharmaceutical compositions containing derivatives and analogs of SDR inhibitors, methods of making derivatives and analogs of SDR inhibitors and methods of use thereof.